Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000696597 | SCV000825162 | uncertain significance | Congenital myasthenic syndrome 8 | 2018-01-29 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with AGRN-related disease. This variant is present in population databases (rs766962416, ExAC 0.03%). This sequence change replaces alanine with threonine at codon 2008 of the AGRN protein (p.Ala2008Thr). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and threonine. |
Genome |
RCV000696597 | SCV001423262 | not provided | Congenital myasthenic syndrome 8 | no assertion provided | phenotyping only | Variant interpretted as Uncertain significance and reported on 02-08-2018 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |